iSpheres
- Company typePrivate
- Founded2016
- HeadquartersParis, France
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
iSpheres firmographics
Firmographics- Name
- iSpheres
- Legal name
- iSpheres
- Website
- https://ispheres.eu
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Where iSpheres is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
iSpheres business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Microsphere Sales: Production and sale of high-precision magnetic and non-magnetic microspheres adapted to client specifications, including calibrated microspheres (>1 µm, monodisperse with CV <10%) and customized microspheres with tailored physical and chemical properties
- Micro-factory Sales: Commercialisation of micro-factories that produce microspheres, sold to customers for in-house production capabilities
- Custom Development Contracts: Contracts for development of specific microspheres with life-sciences industry partners, including industrial-scale supply agreements
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
iSpheres product offering
Product offeringCore offering
iSpheres produces and markets high-precision magnetic and non-magnetic microspheres adapted to client specifications, using proprietary microfluidic processes. The company also commercialises micro-factories that produce microspheres at industrial scale (up to 10 kg/year for sub-10 µm particles). Products serve life-sciences applications such as identification and capture of biomolecules, cells or viruses, and calibration of flow cytometers.
Product overview
iSpheres is a deep tech company offering a portfolio of precision microsphere products and manufacturing equipment. The core offerings include calibrated microspheres (sizes >1 µm, monodisperse with CV<10%), customized microspheres with tailored physical/chemical properties, magnetic microspheres with silica coating for life-science applications, and functionalized coatings enabling biomolecule grafting. The company also commercializes micro-factories for industrial-scale microsphere production (up to 10 kg/year for particles below 10 µm). All products utilize plastic-free materials and Green Chemistry processes in compliance with REACH 2022 regulations.
Differentiator
Problem solved
Functional benefit
Products and services
- Calibrated Microspheres High-precision microspheres with sizes above 1 µm, monodisperse with coefficient of variation less than 10%, and homogeneous composition from batch to batch; intended for life-sciences applications.
- Customised Microspheres Microspheres whose physical and chemical properties (including magnetic, optical, or fluorescent characteristics) are tailored to customer specifications for specific life-sciences applications.
- Magnetic Microspheres with Silica Coating Magnetic microspheres (3 µm example) with silica coating, producing precise reagents for life-science applications such as identification and capture of biomolecules, cells or viruses.
- Eco-Friendly Microspheres Microspheres created from plastic-free materials via Green Chemistry processes, with diverse physical properties (magnetic, optical, or fluorescent), in compliance with European REACH 2022 regulations.
- Micro-Factories Industrial-scale micro-factories that iSpheres commercialises to produce microspheres, enabling in-house microsphere manufacturing with current production capacity of up to 10 kg/year for sub-10 µm particles.
Quantifiable outcome
- Production capacity up to 10 kg/year for microspheres below 10 µm
- +2 more outcomes
Companies that use iSpheres
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
iSpheres technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
iSpheres partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- ESPCI (École Supérieure de Physique et de Chimie Industrielles)coreiSpheres is a spin-off from ESPCI's incubation program. The company originated from the Colloids and Divided Materials laboratory led by Jérôme Bibette. Team members continue affiliations with ESPCI including Nicolas Bremond as Senior Lecturer and Jérôme Bibette as Director of the Colloids and Divided Materials Laboratory and Institute of Biological Chemistry and Innovation.
- PSL UniversityminorPSL (Paris Sciences et Lettres) University partner institution shown in logos section of website
- Leading Life Sciences Equipment SuppliercoreSigned contract in 2017 to develop specific microspheres with one of the world's leading suppliers of equipment and reagents for the life-sciences industry. Contract extended in 2019 for industrial-scale supply of microspheres and micro-factories.
Scale indicators5 records
Recent moves3 records
Expansion highlights5 records
iSpheres competitors and assessment
Company assessmentEmerging players
- CD Bioparticles: Specialty manufacturer of magnetic, fluorescent, and functionalized microspheres for diagnostics, drug delivery, and life-science research. Comparable product line to iSpheres with broader catalog and growing presence in life-sciences consumables.
Broad incumbents
- Tosoh Bioscience: Provides chromatography media, separation technologies, and diagnostic consumables including specialty beads. Adjacent competitor in the magnetic-bead and microsphere-based separation/diagnostic space served by iSpheres.
- Cytiva: Life-sciences tools provider offering magnetic beads and microsphere-based products for diagnostics, bioprocessing, and research. Comparable in supplying magnetic microspheres to life-science customers, though at much broader scale and portfolio scope.
- Merck (Sigma-Aldrich): Supplies a wide range of monodisperse and magnetic microspheres for diagnostics, chromatography, and life-science research through the Sigma-Aldrich brand. Directly comparable product category to iSpheres, though Merck operates across thousands of SKUs globally versus iSpheres' specialized niche.
- Bio-Rad Laboratories: Major life-sciences and clinical diagnostics company producing microsphere-based products (including Bio-Plex multiplex assays) and flow-cytometry calibration reagents. Overlaps with iSpheres in flow-cytometry calibration and magnetic-bead diagnostics.
- Thermo Fisher Scientific: Global life-sciences tools leader offering a broad portfolio of calibrated beads, magnetic particles, and flow-cytometry calibration standards. Comparable to iSpheres as a supplier of precision microsphere consumables to diagnostics and research customers, but at vastly greater scale and catalog breadth.
Direct peers
- Polysciences: Specialty manufacturer of monodisperse polymeric, magnetic, and fluorescent microspheres for life sciences, diagnostics, and biomedical research. Closest direct competitor to iSpheres in calibrated, functionalized microspheres, with broader polymer-chemistry offerings.
- Spherotech: Manufacturer of uniform microspheres (polymeric, magnetic, fluorescent) for flow cytometry, immunoassays, and cell separation. Directly comparable niche player to iSpheres with established presence in flow-cytometry calibration beads.
- Bangs Laboratories: Specialist in polymer, magnetic, and silica microspheres for diagnostics, immunoassays, and flow cytometry. Highly comparable to iSpheres in product positioning (precision, functionalized microspheres for life-science applications) and customer base.
- Micromod Partikeltechnologie: German specialty manufacturer of monodisperse magnetic and fluorescent microparticles for diagnostics, biotechnology, and life-science applications. Closely comparable European competitor in precision, calibrated microspheres for life sciences.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
iSpheres social profiles
Digital presenceiSpheres financial estimates
Financial estimateRevenue estimate
Valuation estimate
iSpheres leadership team
Management profileNumber of profiles
Profiles5 records
iSpheres funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
iSpheres M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about iSpheres
What does iSpheres do?
iSpheres produces and markets high-precision magnetic and non-magnetic microspheres adapted to client specifications, using proprietary microfluidic processes. The company also commercialises micro-factories that produce microspheres at industrial scale (up to 10 kg/year for sub-10 µm particles). Products serve life-sciences applications such as identification and capture of biomolecules, cells or viruses, and calibration of flow cytometers.
Is iSpheres a public or private company?
iSpheres is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was iSpheres founded?
iSpheres was founded in 2016. It employs 1 to 10 people.
Where is iSpheres based?
iSpheres is headquartered in Paris, France, in the Europe region.
How does iSpheres make money?
Three revenue lines are on record. Microsphere Sales are the primary driver. The others are micro-factory Sales and custom Development Contracts.
Who are iSpheres's main competitors?
CD Bioparticles is listed as an emerging player. Broad incumbents are Tosoh Bioscience, Cytiva, Merck (Sigma-Aldrich), Bio-Rad Laboratories and Thermo Fisher Scientific. Direct peers are Polysciences, Spherotech, Bangs Laboratories and Micromod Partikeltechnologie.
Does iSpheres have an API?
No public API is recorded for iSpheres.